Defence Therapeutics Inc.
DTCFF
$0.39
$0.0411.57%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.14M | -1.09M | -510.40K | -837.30K | -877.70K |
| Total Depreciation and Amortization | 6.80K | 6.70K | 11.80K | 13.90K | 12.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.21M | 144.50K | 136.20K | 175.60K | 458.00K |
| Change in Net Operating Assets | -226.60K | -64.00K | -160.80K | 52.70K | -983.30K |
| Cash from Operations | -1.14M | -1.00M | -523.20K | -595.10K | -1.39M |
| Capital Expenditure | 0.00 | 4.30K | -15.30K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -10.80K | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 4.30K | -15.30K | -10.80K | 0.00 |
| Total Debt Issued | 0.00 | 0.00 | 2.00M | 0.00 | 0.00 |
| Total Debt Repaid | 0.00 | 0.00 | -15.10K | -3.30K | -22.50K |
| Issuance of Common Stock | 3.60M | 27.80K | -- | 0.00 | 4.22M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -600.00 | -160.10K | -6.90K | -247.40K |
| Cash from Financing | 2.59M | 19.50K | 1.32M | -7.40K | 2.75M |
| Foreign Exchange rate Adjustments | 0.00 | -4.90K | 4.00K | 900.00 | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | -- | -- | 0.00 | -- |
| Net Change in Cash | 1.44M | -985.30K | 790.30K | -612.40K | 1.36M |